AI Governance in Pharmacovigilance: Building Defensible, Compliant AI Workflows for Regulatory Inspections in 2026 and Beyond
Pharmacovigilance teams aren’t being asked whether they use AI anymore — they’re being asked to prove they can control it. That shift is what defines 2026. Regulators have moved beyond curiosity about machine learning in drug safety. They expect pharmaceutical...
